EHRA Premium Access

Validation of a madit-ii derived, primary prevention mortality risk score after implantable cardioverter-defibrillator implantation

Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)

Presentation

About the speaker

Doctor Juan Acosta Martinez

University Hospital of Virgen del Rocio , Seville (Spain)
3 presentations
0 follower

13 more presentations in this session

Which is the benefit of ICD in patients with ischemic cardiomyopathy compare with those with idiopathic dilated cardiomyopathy, from DANISH trial to real life.

Speaker: Doctor A. Tronconi (Buenos Aires, AR)

Thumbnail

Clinical outcomes after implantable cardioverter-defibrillator implantation: does gender matter? a propensity score analysis

Speaker: Doctor J. Acosta Martinez (Seville, ES)

Thumbnail

Are implantable defibrillators less useful in patients with non-ischemic heart disease?

Speaker: Doctor R. Marinheiro (Setubal, PT)

Thumbnail

Survival analysis in patients with and without implantable cardioverter defibrillator for primary prevention indication: a single-centre multiethnic experience

Speaker: Miss A. Ayemon (Nottingham, GB)

Thumbnail

Postextrasystolic blood pressure potentiation is associated with appropriate device therapy and mortality in implantable cardioverter defibrillator recipients with a reduced LVEF

Speaker: Miss A. van der Lingen (Amsterdam, NL)

Thumbnail

Access the full session

Poster session 1 - Sudden cardiac death and implantable defibrillators

Speakers: Doctor J. Acosta Martinez, Doctor A. Tronconi, Doctor J. Acosta Martinez, Doctor R. Marinheiro, Miss A. Ayemon...
Thumbnail

About the event

Image

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk